SINLIP

Sinlip 5 mg: Each tablet contains: Rosuvastatin calcium: 5 mg. 
Sinlip 10 mg: Each tablet contains: Rosuvastatin calcium: 10 mg. 
Sinlip 20 mg: Each tablet contains: Rosuvastatin calcium: 20 mg. 

Sinlip is indicated as treatment of primary hypercholesterolemia (type lla including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type llb), as an adjunct to diet in patients who do not respond adequately to diet or to any other non-pharmacological treatment (exercise, weight loss). Sinlip is also indicated in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and to other lipid-lowering treatments (e.g., LDL apheresis).

View PDF



Full Product Information

Back